Sign up to receive our news roundups

Myanmar Eliminates Trachoma, Togo Eliminates Sleeping Sickness as Public Health Problems & Other NTD News

News roundup

This news roundup is a collection of headlines and other items on neglected tropical diseases, and does not reflect the work or the views of the Neglected Tropical Diseases Support Center.

Myanmar Eliminates Trachoma - FHF

Myanmar today became the latest country to eliminate trachoma, the world’s leading infectious cause of blindness, as a public health problem.
FRED HOLLOWS FOUNDATION/TWITTER

 

Lymphatic filariasis

Study shows benefit of semiannual albendazole to control lymphatic filariasis

Eamon N. Dreisbach
Healio
Semiannual doses of albendazole decreased the average time it took to clear circulating filarial antigenemia in patients with lymphatic filariasis compared with a single or no dose, study findings showed. The results, which were published in Clinical Infectious Diseases, “demonstrate a clear dose-response relationship for the effect of” albendazole (ALB) on clearance of circulating filarial antigenemia (CFA) and microfilaremia, the researchers wrote. “The analyses presented here provide important information regarding the added value of semiannual ALB treatment vs. annual mass drug administration (MDA) or no treatment on lymphatic filariasis (LF) infection parameters,” Cédric B. Chesnais, MD, PhD, of the French National Research Institute for Sustainable Development, and colleagues wrote. “Our results show that good adherence leads to faster clearance of LF infection in individuals.”

A Multicountry Comparison of Three Coverage Evaluation Survey Sampling Methodologies for Neglected Tropical Diseases

Katherine Gass et al.
The American Journal of Tropical Medicine and Hygiene
Coverage evaluation surveys (CESs) are an important complement to routinely reported drug coverage estimates following mass drug administration for neglected tropical diseases (NTDs). Although the WHO recommends the routine use of CESs, they are rarely implemented. Reasons for this low uptake are multifaceted; one is uncertainty on the best sampling method. We conducted a multicountry study to compare the statistical characteristics, cost, time, and complexity of three commonly used CES sampling methods: the Expanded Program on Immunization’s (EPI’s) 30 × 7 cluster survey, a stratified design with systematic sampling within strata to enable lot quality assurance sampling (S-LQAS) decision rules, and probability sampling with segmentation (PSS).

Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja...

Alfred Kwesi Manyeh, Latifat Ibisomi, Rohit Ramaswamy, Frank Baiden and Tobias Chirwa
PLOS Neglected Tropical Diseases
Ghana has been implementing Mass Drug Administration (MDA) since the year 2001, and Lymphatic Filariasis transmission has been interrupted in 76 out of the 98 targeted districts. The remaining districts have a microfilaria prevalence above the 1% threshold needed for the interruption of transmission. This study assesses the level of lymphatic filariasis MDA coverage and explored factors affecting the quality of implementation of the MDA in the Bole and Central Gonja Districts of Northern Ghana

Public consultation: Target Product Profiles for diagnostic tests to meet Lymphatic Filariasis programme needs...

Jonathan King
World Health Organization
Lymphatic filariasis (LF) is a mosquito-borne parasitic infection that is endemic in 72 countries. In 2017, WHO recommended the combination of ivermectin, DEC, and albendazole, known as IDA or triple-therapy for use in mass drug administration (MDA) in certain settings. Use of IDA is projected to reduce the number of MDA rounds required to reduce infection and transmission to unsustainable levels, but current diagnostic tools are targeted to biomarkers that do not provide an indicator of the immediate impact on reducing transmission. New diagnostic tools are needed to identify, clarify and make decisions for stopping IDA MDA. Similarly, the success of MDA in endemic countries has meant that an increasing number of countries no longer require MDA nationally for LF. This means that monitoring for resurgence becomes an ever-more important consideration. New diagnostic tests are needed to serve as early indicators of significant transmission potential leading to new infections and a re-emerging public health problem. The World Health Organization (WHO) is asking for feedback on both TPPs. Feedback is invited from experts in the industry, product development, parasitologists, the scientific community, NTD programme personnel and other technicians currently implementing WHO recommended LF surveys.

Onchocerciasis

Stanford students design a device to detect early-stage river blindness

Stacey Paris McCutcheon
Stanford SCOPE
The team set out to develop a less-invasive, more accurate way to diagnose and monitor patients. Their breakthrough came after they read a study that used blue light to transform the capillary beds of the fingernails into a noninvasive window into the bloodstream. "In blue light, red blood cells appear dark, and white blood cells and the parasites we were trying to identify are optically clear," said MacAvoy. "So we decided to build a low-cost microscope that could detect the disease by using blue light to image the fingernail beds." There was just one problem. "None of us had any idea how to build a microscope," said Wysong. "But we all learned together with some key guidance from Dr. Prakash, who connected us with folks in his lab to help us better understand the optics physics." By the time the course was drawing to a close, the team had developed a working prototype of a device they named the onchoscope. "The idea is that a health worker can use the onchoscope to image the patient's hand, then use our computer algorithm to get a yes/no diagnosis as well as a microfilarial count to accurately measure the parasitic load," said Lamadrid.

Mectizan Donation Program 2019 Annual Highlights

Mectizan Donation Program
In 2019, MDP approved a total of 403.6 million treatments, including 343.3 million treatments in countries where LF and onchocerciasis are co-endemic and 60.3 million treatments in IDA countries. The push to accelerate LF elimination in countries where onchocerciasis is not co-endemic continued in 2019. Year 2 of the implementation of “triple therapy” or the “IDA” strategy (ivermectin [Mectizan®], diethylcarbamazine [DEC] and albendazole) continued; 13 countries are now implementing IDA (see Where We Work map). Yemen achieved a major milestone in 2019 when the World Health Organization (WHO) validated elimination of LF as a public health problem. Given the challenges in Yemen, this is a remarkable achievement that demonstrates the long-standing commitment of the Ministry of Health and endemic communities. Yemen is now the second country after Togo to achieve LF elimination where onchocerciasis and LF are co-endemic.

Schistosomiasis

Integration of prevention and control measures for female genital schistosomiasis, HIV and cervical cancer

Dirk Engels et al.
Bulletin of the World Health Organization
Several relevant global initiatives are already in place: the sustainable development goals, including universal health coverage; the 2016 United Nations political declaration on HIV; the HIV prevention 2020 road map and the H6 partnership to advance the Every Woman Every Child global strategy. The current global health environment offers opportunities to combine disease-specific initiatives; strengthen health systems at all levels to provide integrated, comprehensive and quality services; and to address the multifaceted and intersecting health, sociocultural, gender and economic issues facing women and girls. Integrated approaches, which have a strong rights-based approach, and which join up multiple public health programmes, create new opportunities and expand existing ways to reach more girls and women throughout their life span. In addition, an integrated approach provides opportunities to mobilize new resources and use existing resources more effectively. Building on lessons learnt from the response to the HIV epidemic, we need to expand and diversify partnerships beyond the traditional biomedical public health communities to engage advocates for sexual and reproductive health rights and women’s rights. Such expanded partnerships will help to position comprehensive prevention and control of female genital schistosomiasis, HIV and cervical cancer within the broader sexual and reproductive health and rights, women’s empowerment and social justice framework.

An outbreak of intestinal schistosomiasis: What lies ahead for Malawi?

Angus O’Ferrall, Hamish Baxter and Sekeleghe Kayuni
BugBitten
Malawi is endemic for urogenital schistosomiasis, however reports of intestinal schistosomiasis have pointed to the emergence of Schistosoma mansoni in the area. In this blog, researchers from the Liverpool School of Tropical Medicine confirm that an outbreak of intestinal schistosomiasis is occuring in the Mangochi District and discuss the epidemiological and public health implications in Malawi.

Worming Out

Anthony Lewis
Biomedical Picture of the Day
[Click the link above to access the photo.] In some parts of the world, a refreshing dip in a lake can carry a heavy cost, if the water is contaminated with parasites. Schistosomiasis is a tropical disease spread by contact with fresh water containing parasitic worms, such as the Schistosoma mansoni (pictured, left). Treatment is limited to one anti-worm drug, and there's a pressing need for new ways to tackle this parasite. A new study tested whether a particular enzyme in the worm might be a potential vulnerability to target. They treated adult and juvenile worms with MC3935, a drug that inhibits the behaviour of an enzyme usually involved in the restructuring of DNA. Worms treated with the drug were severely damaged (right), and died within four days. The treatment disrupted much of the usual function of the parasite, and could be the basis for a new, specific drug to help patients with this debilitating condition.

Soil-Transmitted Helminthiasis

Parasitic worms found in medieval human remains hold secret for eradicating them today

Michael Price
Science
Fingernail-size roundworms are a scourge in less economically developed countries, where they cause diarrhea, stunt children’s growth, and even kill. A new study suggests these parasites were just as common in medieval Europe as they are today, suggesting Europe’s later improvements to hygiene and sanitation proved enough to conquer them. The new study is “extensive and well done,” says Roger Prichard, a parasitologist at McGill University who was not involved with the work. It confirms, he says, that Europe’s successful eradication efforts weren’t simply the result of naturally low parasite numbers. . . Chemotherapeutic drugs developed in the 1960s can eradicate these worms, but medical records reveal that Europe was largely helminth-free by the beginning of the 20th century (though it flared up in the trenches of World War I). This suggests Europe’s improvements to plumbing, hygiene, and sanitation made the difference, Smith and colleagues conclude. And that, in turn, reinforces the World Health Organization’s calls, along with other groups, for those improvements in other nations, he says. “These sorts of changes that happened in Europe are very powerful.”

Trachoma

Terminating Trachoma: How Myanmar eliminated blinding Trachoma

World Health Organization Regional Office for South-East Asia
Eliminating diseases on the verge of elimination on is one of the South-East Asia Region’s eight Flagship Priorities. In 2005, trachoma – an easily preventable disease – was responsible for 4% of all cases of blindness in Myanmar. By 2018 the population prevalence of trachoma was down to a mere 0.008%. Across Myanmar, trachoma is no longer a public health problem. To eliminate trachoma, Myanmar adopted a multi-pronged approach that promoted access to good hygiene infrastructure and clean water, and which strengthened the country’s multi-tiered eye care system to enhance prevention and treatment. These interventions, coupled with behavioural change campaigns that achieved widespread buy-in, rapidly reduced the impact of the disease, ensuring that people of all ages could look towards a trachoma-free future with less poverty and enhanced development and well-being.

Q&A with Sarah Boyd: how we are moving Tropical Data forward through COVID-19

Sightsavers
Like any other team, COVID-19 has greatly affected our lives and interrupted our ‘normal’. However, we are fortunate that we’re used to working in different locations and time zones: we’re already accustomed to holding weekly virtual team calls and had a system for working remotely together. Normally, Tropical Data is supporting active survey projects all the time, but as health ministries take precautions against COVID-19, trachoma work has slowed down. There are no active surveys in the field at the moment, but we can still prepare for when teams can start surveys again! In collaboration with health ministries, Tropical Data has continued to work on preparing protocols and supporting planning, so the projects are ready for when field work is able to resume.

Cross-cutting

Disease treatments restart in Africa as COVID-19 restrictions ease

ReliefWeb
Nigeria is the first country that Sightsavers and partners has supported to resume work on NTDs, which can have a devastating impact on some of the poorest communities in the world, with other African countries due to follow soon. In April, the threat of COVID-19 led the World Health Organization to recommend suspending mass treatment campaigns, which treat and prevent these diseases, but it has since provided guidance on restarting activities safely. A rigorous assessment process was conducted in line with this guidance before mass NTD treatments resumed in Nigeria. Health ministries in Guinea, Zimbabwe, Zanzibar, Cameroon, Burkina Faso and Senegal are currently working with Sightsavers and partners to conduct similar assessments in the hope of resuming NTD activities in the coming months.

The Programs Boosting Health Research Across Africa

U.S. News & World Report
Our analysis also highlighted research gaps and made recommendations for future research. The research into noncommunicable diseases was less extensive than the number of studies conducted on TB and HIV. This is despite the increased number of noncommunicable diseases being recorded in African countries. Considering the high burden of neglected tropical diseases in sub-Saharan Africa, there were also very few papers in this area.

The Mind Skin Link: new project will improve mental health and tackle stigma for people with Neglected Tropical Diseases

CBM
A new project in Nigeria will help to improve mental health support for people living with diseases like leprosy and lymphatic filariasis. Many people living with these conditions experience poor mental wellbeing, particularly depression and anxiety, often resulting from the rejection, stigma and discrimination they face due to physical impairment. . . CBM Global’s Mental Health Director, Julian Eaton, who contributed to the WHO NTD and Mental Health Manual, explains: “We know that a very high proportion of people with diseases like leprosy experience conditions like depression and anxiety so it’s vital that projects to tackle these diseases also address mental health. But currently, there is little guidance for organisations or governments about how to do this. This pilot project, offering improved psychosocial support for people with lived experience of these diseases, will not only benefit the individuals in Benue State themselves, but will help fill this gap in knowledge and to share increased understanding of their priorities and needs. We hope this will not only help to inform other organisations and guide them in their interventions but also provide evidence of the need for more financial investment in the area of mental health and NTDs in the world’s poorest communities.”

Ethiopian Commercial Farms Weed Out Tropical Diseases

The Carter Center
Programs to combat neglected tropical diseases usually are aimed at people in villages at the end of the road and occasionally in big cities where all roads lead. . . "To achieve elimination, we must ensure everyone in endemic areas is protected, including people who travel from all over the country for temporary work on commercial farms," said Aderajew Mohammed, the Carter Center's Ethiopia health program director. "The Federal Ministry of Health is doing excellent work toward interrupting transmission of these diseases. We have a very good and effective working relationship with the ministry."

Transforming lives: Ascend West and Central Africa: Celebrating success 2019-2020

Ascend
In 2019 the UK Government launched Ascend, its flagship programme for the sustainable control and elimination of neglected tropical diseases (NTDs). Working in partnership with communities, national governments, ministries of health and partners including the World Health Organization (WHO), Ascend West and Central Africa will protect millions of people by making major progress towards the control or elimination of five painful and poverty trapping NTDs: intestinal worms, lymphatic filariasis, river blindness, schistosomiasis and trachoma.

Winners of the NTD Innovation Prize Announced

NTD NGO Network
Twitter
Winning $15,000: Early diagnosis is critical to treat #leprosy, but we need more field-friendly tools to give rapid & accurate results. @LeprosyResearch & @universitately #NTDinnovate project proposes spectral imaging & #mobile tech to identify leprosy-affected skin. Winning $20,000: Molecular diagnostics could be an alt. to tools like skin biopsies, for #onchocerciasis diagnosis, but #DNA extraction takes $$ & time. The #NTDinnovate project from CRFilMT in #Cameroon explores use of cell-free #DNA in saliva & urine.

Other

Togo is first African country to end sleeping sickness as a public health problem

World Health Organization
Togo has received validation from the World Health Organization (WHO) for having eliminated human African trypanosomiasis or “sleeping sickness” as a public health problem, becoming the first country in Africa to reach this milestone. . . Togo’s achievement comes after more than two decades of sustained political commitment, surveillance and screening of cases. Beginning in 2000, the country’s public health officials implemented control measures. In 2011, the country established surveillance sites at hospitals in the cities of Mango and Tchamba, which cover the main areas at risk of the disease. Public health officials have since maintained heightened disease surveillance in endemic and at-risk areas.

Africa Kicks Out Wild Polio

World Health Organization Regional Office for Africa
In 1996, the great African leader Nelson Mandela launched the Kick Polio Out of Africa campaign with Rotary International’s support, setting out a vision for a polio-free Africa. At the time, wild polio paralysed 75,000 children each year. To protect communities from this crippling disease, African leaders, health workers, volunteers, parents, global donors and organizations united to reach every child with polio vaccines. On 25 August 2020, after four years without a single case of wild polio, the African region has been certified free of wild poliovirus. Decades of extraordinary investment has paid off. Yet, the job is not finished. These efforts must continue to prevent wild polio from returning and to end all forms of polio for good – both in Africa and globally.

Countries should step-up leprosy prevention initiatives to accelerate decline in new cases

Emily Henderson
NewsMedical
New cases of leprosy are decreasing, but not at the anticipated rate. In order to accelerate the annual decline, countries should screen contacts and treat eligible contacts with single-dose rifampicin, as recommended by the World Health Organization (WHO) in its guidelines. "Research evidence with single‐dose rifampicin given as post-exposure prophylaxis to contacts of newly diagnosed patients has shown a reduction of 50–60% in developing leprosy over the following 2 years. Programmes should identify and manage contacts of persons with leprosy." - Dr Erwin Cooreman, Team Leader, WHO Global Leprosy Programme

Guinea Worm Wrap-Up #270

U.S. Centers for Disease Control and Prevention
The Carter Center
Angola, Chad, Ethiopia, Mali, and South Sudan have together reported 19 indigenous human cases of Guinea worm disease in January-July 2020, compared to 41 cases reported by Angola, Cameroon, Chad and South Sudan during the same period of 2019. This number demonstrates a global reduction of 51% in human cases in these countries.

Zika Infection Increases Risk of Severe Dengue Fever

Ruth Williams
The Scientist
The 2015–16 Zika virus epidemic that spread through Central and South America was followed last year by a surge in dengue virus cases. While this unfortunate series of diseases battered the region’s populace, it gave scientists, who had been following a cohort of several thousand children in the area, the opportunity to study how these two flaviviruses might jointly affect the immune system. That research has revealed that kids infected with dengue virus are more likely to suffer worse symptoms if they had previously been infected with Zika than if they hadn’t.

UK Commonwealth Chair-in-Office report 2018 to 2020: delivery of Commonwealth Summit commitments

Foreign, Commonwealth & Development Office
Gov.UK
This report provides a comprehensive overview of Commonwealth outcomes and achievements based on the CHOGM 2018 Leaders commitments. It describes the UK government’s work in partnership with other Commonwealth countries, intergovernmental and affiliated organisations on projects worth £500 million across 6 continents for the Commonwealth’s 2.4 billion citizens. Taking action in areas such as girl’s education, trade facilitation and marine plastics, these projects aimed to make the Commonwealth fairer, more prosperous, more sustainable and more secure.

The Celebration Continues for FETP’s 40th Anniversary

U.S. Centers for Disease Control and Prevention
CDC continues to celebrate the 40th anniversary of the Field Epidemiology Training Program (FETP) and its more than 18,000 graduates in 80 countries. These dedicated public health professionals are our “boots on the ground” in the ongoing battle against infectious diseases, public health emergencies, and chronic diseases.

COVID-19

Register now for the NTDs Idea Forum: Programme Innovation in a #COVID19 Context

Bill & Melinda Gates Foundation
The novel SARS-CoV2 coronavirus has affected everyone around the world, infecting millions and killing hundreds of thousands, shutting down economies, and disrupting essential health services and disease control programmes – including those for neglected tropical diseases (NTDs). It is increasingly clear that the public health landscape in which NTD programmes are operating will be changed, and programmes will need to adjust how they deliver interventions in ways that minimize the risks of SARS-CoV2 transmission, while also enhancing the efficiency and impact of programmes to catch-up on lost progress due to related disruptions. The drastic changes brought about by COVID-19 has created space and necessity for developing and testing new innovative tools and strategies for NTDs. In response, the Bill & Melinda Gates Foundation, Children’s Investment Fund Foundation, ELMA Philanthropies, the UK Foreign, Commonwealth and Development Office, and the Expanded Special Project for Elimination of NTDs at WHO AFRO are pleased to host the upcoming NTDs Idea Forum: Programme Innovation in a Covid-19 context. Through a series of virtual meetings to unite NTD control programmes, implementing and technical partners, and donors as they consider how NTD programmes might need to change in response to the COVID-19 pandemic. Register now to join us as we discuss current challenges, exchange lessons, and even apply for a chance to pitch an idea for potential funding.

WHO, UNICEF urge safe school reopening in Africa

World Health Organization Regional Office for Africa
The unprecedented and prolonged school closures aimed at keeping students safe from COVID-19 are harming them in other ways, World Health Organization (WHO) and UNICEF said today, urging governments in Africa to promote the safe reopening of schools while taking measures to limit the spread of the virus. A WHO survey of 39 countries in sub-Saharan Africa found that schools are fully open in only six countries. They are closed in 14 countries and partially open (exam classes) in 19 others. Around a dozen countries are planning to resume classroom learning in September, which is the start of the academic year in some countries. However, the impact of extended education disruption is significant. It includes among others: poor nutrition, stress, increased exposure to violence and exploitation, childhood pregnancies, and overall challenges in mental development of children due to reduced interaction related to school closures.

America Doesn’t Have a Coherent Strategy for Asymptomatic Testing. It Needs One.

Caroline Chen
ProPublica
Let’s start with the most basic question: Why do we bother testing in the first place? There are, broadly speaking, two reasons to use a test. The first is as a clinical diagnostic; the other is as a public health tool. Both are important, but for different reasons. Doctors use a clinical diagnostic like a strep test to tell whether a patient is sick with a disease that can be treated with particular medicines. “The purpose of the test is based around doing one thing when it’s negative and doing another thing when it’s positive,” said Dr. Patrick O’Carroll, head of health systems strengthening at the Task Force for Global Health, who previously worked at the CDC for 18 years.

UPCOMING EVENTS

NOTE - Events may be postponed or cancelled due to the COVID-19 pandemic. Please check with event organizers to confirm events.

75th Session of the UN General Assembly - VIRTUAL
September 15-30, 2020
All 193 Member States of the Organization are represented in the General Assembly - one of the six main organs of the UN - to discuss and work together on a wide array of international issues covered by the Charter of the United Nations, such as development, peace and security, international law, etc. Every year in September, all the Members meet in this unique forum for the General Assembly session.

Is it business as usual? What innovation is needed in NTDs to reach the 2030 targets across 20 diseases
September 16, Webinar
Webinar of the World Health Organization

Women in Global Health Security Summit
September 17, Virtual Event
Women in Global Health (WGH), together with the Wagner Foundation and Foreign Policy are hosting the Women in Global Health Security Summit during the UN General Assembly. This virtual event is intended to start a conversation about gender-transformative policies and global health security that will last beyond the current pandemic and build future resilience.

Approaching schistosomiasis elimination: from mass treatment to targeted interventions
September 18, COR-NTD Pre-meeting Webinar
COR-NTD and the Global Schistosomiasis Alliance (GSA) are pleased to announce a pre-meeting session. The overall aim of this session is to identify operational research needs and questions that can help guide successful schistosomiasis programs from the morbidity control stage towards elimination of schistosomiasis as public health problem and interruption of transmission. Specifically, in the session, we will hear about and discuss existing and novel tools and strategies needed on the last mile towards interrupting transmission.

GAELF 11
September 29 - October 1, 2020, Lomé, Togo
More details to follow.

What role does disability and stigma play in planning elimination, eradication and control of NTDs?
October 7, Webinar
Webinar of the World Health Organization

Meet the Social Innovators
October 7, 2020, Webinar
How can innovators, governments, researchers and foundations work together to advance social innovation in health efforts through research and guided by strong evidence?  

World Sight Day
October 9, 2020
World Sight Day (WSD) is an annual day of awareness held on the second Thursday of October, to focus global attention on blindness and vision impairment. World Sight Day 2020 is on 9 October 2020.

11th IAPB General Assembly - POSTPONED
October 12-14, 2020, Singapore
The General Assembly will mark the end of the VISION 2020: The Right to Sight period. It will present a great opportunity to take stock, celebrate successes and make plans for the future. A key focus will be on the WHO’s World Report on Vision and its framework for the future. The event will have three co-chairs leading on three streams: “Excellence”, “Eye Health in the West Pacific” and “Sustainability”. 

Run the TCS NYC Marathon to help beat NTDs… wherever you are!
October 17 - Noember 1, 2020, Online
The General Assembly will mark the end of the VISION 2020: The Right to Sight period. It will present a great opportunity to take stock, celebrate successes and make plans for the future. A key focus will be on the WHO’s World Report on Vision and its framework for the future. The event will have three co-chairs leading on three streams: “Excellence”, “Eye Health in the West Pacific” and “Sustainability”. 

Expo 2020 Dubai: Global Best Practice Programme
October 20 2020 - April 10, 2021
Although we may not be able to run together in person thi year, you can enter the TCS New York City Marathon virtually, from wherever you are! By joining Team END Fund, you can support the END Fund's mission all while participating in the world-renowned TCS New York City Marathon from the comfort of your own town or city.

Skin deep – How do we deal with skin diseases to reach the 2030 NTD Road Map?
October 21, Webinar
Webinar of the World Health Organization

World Health Summit 
October 25-27, 2020, Berlin, Germany
The World Health Summit is one of the world’s leading strategic forums for global health. Held annually in Berlin, it brings together leaders from politics, science and medicine, the private sector, and civil society to set the agenda for a healthier future. 300 speakers and 2,500 participants from 100 countries take part.

6th World One Health Congress 
October 30 - November 3, 2020, Edinburgh, Scotland
The 6th World One Health Congress is the largest One Health event of the year, where experts and researchers from around the world present their latest scientific research.

Optimizing One health and Global Vector Control Response to reach the 2030 NTD Roadmap goals
November 10, 2020, Webinar
Webinar of the World Health Organization

#TropMed20 - Annual Meeting of the American Society of Tropical Medicine & Hygiene
November 15-19, 2020, Virtual Meeting
The ASTMH Annual Meeting draws tropical medicine and global health professionals representing academia, foundations, government, not for profit organizations, non-governmental organizations, the private sector, military and private practice. The meeting is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students and all healthcare providers working in the fields of tropical medicine, hygiene and global health

What role do partnerships play in NTDs and the roll out of the new Roadmap?
December 2, 2020, Webinar
Webinar of the World Health Organization

The leadership needed to stimulate the battle against NTDs
December 16, 2020, Webinar
Webinar of the World Health Organization